BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23703544)

  • 1. Para-aminobenzamidine linked regenerated cellulose membranes for plasminogen activator purification: effect of spacer arm length and ligand density.
    Fasoli E; Reyes YR; Guzman OM; Rosado A; Cruz VR; Borges A; Martinez E; Bansal V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 930():13-21. PubMed ID: 23703544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of p-aminobenzamidine-based sorbent and its use for high-performance affinity chromatography of trypsin-like proteases.
    Nakamura K; Suzuki T; Hasegawa M; Kato Y; Sasaki H; Inouye K
    J Chromatogr A; 2003 Aug; 1009(1-2):133-9. PubMed ID: 13677653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellulose and glass fiber affinity membranes for the chromatographic separation of biomolecules.
    Ruckenstein E; Guo W
    Biotechnol Prog; 2004; 20(1):13-25. PubMed ID: 14763818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel biomimetic affinity ligands for human tissue plasminogen activator.
    Wu F; Yu J; Li R
    Biochem Biophys Res Commun; 2007 Apr; 355(3):673-8. PubMed ID: 17307143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance affinity chromatography of plasmin and plasminogen on a hydrophilic vinyl-polymer gel coupled with p-aminobenzamidine.
    Shimura K; Kazama M; Kasai K
    J Chromatogr; 1984 Jun; 292(2):369-82. PubMed ID: 6235238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
    Husain SS; Lipinski B; Greuwich V
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monolithic sorbents modified by directly synthesized peptides for affinity separation of recombinant tissue plasminogen activator (t-PA).
    Vlakh E; Ostryanina N; Jungbauer A; Tennikova T
    J Biotechnol; 2004 Feb; 107(3):275-84. PubMed ID: 14736463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New type of plasminogen activator produced by an established cell line from human ovary.
    Matsuo O; Fukao H; Matsuo C; Ueshima S
    Thromb Res Suppl; 1988; 8():45-55. PubMed ID: 3144768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immobilized IDA-type Cu2+-chelating membrane affinity chromatography for purification of bovine liver catalase.
    Yang L; Jia L; Zou H; Kong L; Zhang Y
    Se Pu; 1997 Jul; 15(4):292-5. PubMed ID: 15739458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding ligand-protein interactions in affinity membrane chromatography for antibody purification.
    Boi C; Busini V; Salvalaglio M; Cavallotti C; Sarti GC
    J Chromatogr A; 2009 Dec; 1216(50):8687-96. PubMed ID: 19535082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of plasminogen activator from Rous sarcoma virus-infected chick embryo fibroblast culture medium.
    Kacian DL; Harvey RC
    Arch Biochem Biophys; 1985 Jan; 236(1):354-69. PubMed ID: 2981508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin binding, fibrinolytic and fibrinogenolytic activity of plasminogen activator derived from the paranasal mucous membrane of humans.
    Yamashiro Y; Nakamura M; Huang GW; Kosugi T
    Laryngoscope; 1993 Feb; 103(2):197-202. PubMed ID: 8426513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of plasminogen activator from two human renal carcinoma cell lines.
    Nelson NF; Cieplak W; Dacus SC; Prager MD
    J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.
    Heussen C; Joubert F; Dowdle EB
    J Biol Chem; 1984 Oct; 259(19):11635-8. PubMed ID: 6541221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of hepatocyte growth factor using polyvinyldiene fluoride-based immobilized metal affinity membranes: equilibrium adsorption study.
    Tsai YH; Wang MY; Suen SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):133-43. PubMed ID: 11820289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of different spacer arms on Mimetic Ligandâ„¢ A2P and B14 membranes for human IgG purification.
    Boi C; Dimartino S; Hofer S; Horak J; Williams S; Sarti GC; Lindner W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1633-40. PubMed ID: 21531180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of peptide ligand for affinity chromatography of tissue-type plasminogen activator by the combination of docking and molecular dynamics simulations.
    Liu FF; Dong XY; Wang T; Sun Y
    J Chromatogr A; 2007 Dec; 1175(2):249-58. PubMed ID: 17996243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of penicillin G acylase using immobilized metal affinity membranes.
    Liu YC; ChangChien CC; Suen SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Aug; 794(1):67-76. PubMed ID: 12888199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.